EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Hemoptysis in Cancer Patients

Emad D Singer iD, Saadia A Faiz iD, Aiham Qdaisat iD, Karim Abdeldaem iD, Jim Dagher, Patrick Chaftari iD, Sai-Ching J Yeung iD

Cancers · 28.09.2023 · 15 (19) · 4765

DOI: 10.3390/cancers15194765 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 28.09.2023. Verfasst von Emad D Singer und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hemoptysis in cancer patients can occur for various reasons, including infections, tumors, blood vessel abnormalities and inflammatory conditions. The degree of hemoptysis is commonly classified according to the quantity of blood expelled. However, volume-based definitions may not accurately reflect the clinical impact of bleeding. This review explores a more comprehensive approach to evaluating hemoptysis by considering its risk factors, epidemiology and clinical consequences. In particular, this review provides insight into the risk factors, identifies mortality rates associated with hemoptysis in cancer patients and highlights the need for developing a mortality prediction score specific for cancer patients. The use of hemoptysis-related variables may help stratify patients into risk categories; optimize the control of bleeding with critical care; implement the use of tracheobronchial or vascular interventions; and aid in treatment planning. Effective management of hemoptysis in cancer patients must address the underlying cause while also providing supportive care to improve patients’ quality of life.

Schlagwörter

Stichwörter der Autor:innen

canceretiologyhemoptysisinvestigationslung cancermanagementoncologyprediction scoreprognosisrisk factors

Autor:innen und Institutionen

  • Department of Emergency Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Department of Abdominal Imaging, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Faculty of Medicine, Saint Joseph University of Beirut, Beirut 1100, Lebanon.

ORCID-Profile: Emad D Singer, Saadia A Faiz, Aiham Qdaisat, Karim Abdeldaem, Patrick Chaftari, Sai-Ching J Yeung

Zitieren

APA

Singer, E. D., Faiz, S. A., Qdaisat, A., Abdeldaem, K., Dagher, J., Chaftari, P., & Yeung, S. J. (2023). Hemoptysis in Cancer Patients. Cancers, 15(19), 4765. https://doi.org/10.3390/cancers15194765

Vancouver

Singer ED, Faiz SA, Qdaisat A, Abdeldaem K, Dagher J, Chaftari P, et al. Hemoptysis in Cancer Patients. Cancers. 2023;15(19):4765. doi:10.3390/cancers15194765

BibTeX
@article{Singer2023,
  author = {Singer, Emad D and Faiz, Saadia A and Qdaisat, Aiham and Abdeldaem, Karim and Dagher, Jim and Chaftari, Patrick and Yeung, Sai-Ching J},
  title = {Hemoptysis in Cancer Patients},
  journal = {Cancers},
  year = {2023},
  volume = {15},
  number = {19},
  pages = {4765},
  doi = {10.3390/cancers15194765}
}
Kostenlos starten →